Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kerstin Kühn‐Wache
Observed names:
K. Kühn-Wache,
Kerstin Kuehn-Wache,
Kerstin Kuhn‐Wache,
Kerstin Kühn-Wache,
Kerstin Kühn-Wache
Observed institutions:
University of Copenhagen,
Probiodrug (Germany),
Amsterdam University Medical Centers,
Amsterdam UMC Location Vrije Universiteit Amsterdam
OpenAlex ID:
A5058824118
Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon
2000
·
Simon Amadeus Hinke
, J.Andrew Pospisilik
, et al.
·
Journal of Biological Chemistry
·
122
Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1
2002
·
Simon A. Hinke
, Kerstin Kühn-Wache
, et al.
·
Biochemical and Biophysical Research Communications
·
103
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects
2015
·
Inge Lues
, Frank Weber
, et al.
·
Alzheimer s & Dementia Translational Research & Clinical Interventions
·
62
PDF
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD
2021
·
E. G. B. Vijverberg
, T. M. Axelsen
, et al.
·
Alzheimer s Research & Therapy
·
45
PDF
Analogs of Glucose-Dependent Insulinotropic Polypeptide With Increased Dipeptidyl Peptidase IV Resistance
2006
·
Kerstin Kühn-Wache
, Susanne Manhart
, et al.
·
Kluwer Academic Publishers eBooks
·
25
Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site
2011
·
Kerstin Kühn-Wache
, Joachim W. Bär
, et al.
·
Biological Chemistry
·
23
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease
2024
·
Howard H. Feldman
, for the ADCS VIVA-MIND Study Group
, et al.
·
Journal of Alzheimer s Disease
·
22
Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP)
2003
·
S.A. Hinke
, R. Gelling
, et al.
·
Biological Chemistry
·
22
[Ser2]- and [Ser(P)2]Incretin Analogs
2004
·
Simon A. Hinke
, Susanne Manhart
, et al.
·
Journal of Biological Chemistry
·
20
Glucose-dependent Insulinotropic Polypeptide (GIP): Development of DP IV-Resistant Analogues with Therapeutic Potential
2005
·
Simon A. Hinke
, Francis Lynn
, et al.
·
Kluwer Academic Publishers eBooks
·
14
On Combination Therapy of Diabetes With Metformin and Dipeptidyl Peptidase IV Inhibitors
2002
·
Simon A. Hinke
, Christopher H. S. McIntosh
, et al.
·
Diabetes Care
·
11
PDF
The Specificity of DP IV for Natural Substrates is Peptide Structure Determined
2004
·
Kerstin Kühn-Wache
, Torsten Hoffmann
, et al.
·
Advances in experimental medicine and biology
·
10
Isolation and Characterization of Attractin-2
2005
·
Daniel Friedrich
, Kerstin Kühn-Wache
, et al.
·
Kluwer Academic Publishers eBooks
·
8
Acylated Hydroxamates as Selective and Highly Potent Inhibitors of Dipeptidyl Peptidase I
2005
·
André J. Niestroj
, Dagmar Schlenzig
, et al.
·
Kluwer Academic Publishers eBooks
·
3
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease
2024
·
Howard H. Feldman
, the ADCS VIVA-MIND Study Group
, et al.
·
Advances in Alzheimer's disease
·
1
A novel, efficient and seamless Phase 2A‐2B design to test varoglutamstat in early AD: the VIVA‐MIND study
2022
·
Karen Messer
, Diane M. Jacobs
, et al.
·
Alzheimer s & Dementia
·
1
Rationale and study-design of a randomized, placebo-controlled, double-blind phase 2b trial to Evaluate Efficacy, Safety and Tolerability of an oral glutaminyl cyclase inhibitor Varoglutamstat (PQ912) in Study participants With MCI and Mild AD - VIVIAD
2021
·
E.G.B. Vijverberg
, T.M. Axelsen
, et al.
·
Research Square
PDF
Peptihormone - Substrate Prolinspezifischer Proteasen
2001
·
Kerstin Kühn‐Wache
·
Kölner Universitäts PublikationsServer (Universität zu Köln)
Show more works
View as search
Works count:
18
Citation count:
492
H-index:
11
I10-index:
12
Year
Topic
Type
